Showing results (141-150 of 157) with videos related to
Sort By:
Pageof 16
Clinical Endocrinology|January 1, 1994
The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjectsD A Cavan, M A Penny, K H Jacobs, et al.Journal of Neurochemistry|January 14, 1999
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatumS D Dickinson, J Sabeti, G A Larson, et al.International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|January 1, 1979
Effects of high-LET neon (20Ne) particle radiation on the brain, eyes and other head structures of the pocket mouse: a histological studyL M Kraft, M A Kelly, J E Johnson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1996
A study of oligoclonal band negative multiple sclerosisA Z Zeman, D Kidd, B N McLean, et al.Brain Research. Molecular Brain Research|October 20, 2000
Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient miceK Y Tseng, C Roubert, L Do, et al.Human Immunology|June 1, 1994
Analysis of a Chinese population suggests that the TNFB gene is not a susceptibility gene for Graves' diseaseD A Cavan, M A Penny, K H Jacobs, et al.Neuron|July 1, 1997
Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient miceM A Kelly, M Rubinstein, S L Asa, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1995
Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studiesS P Morrissey, F X Borruat, D H Miller, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 1998
Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptationsM A Kelly, M Rubinstein, T J Phillips, et al.Journal of the National Cancer Institute|February 3, 2000
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaG N Hortobagyi, A U Buzdar, R L Theriault, et al.Pageof 16